Experimental study demonstrates efficient pharmaceutical removal using biochar-supported cerium catalysts under neutral pH, suggesting a safe, reusable approach for wastewater treatment.
Biochar-supported rare earth oxides are herein assessed as heterogeneous catalysts for the UV-assisted Catalytic Wet Peroxide Oxidation (UV-CWPO) treatment of pharmaceuticals under mild conditions. Catalysts were synthesized by two different pyrolysis methods (activated carbon-assisted oxygen-limited pyrolysis in a muffle furnace, and inert-gas pyrolysis in a tubular furnace under nitrogen flow), and characterized by XRD, SEM, and N2 adsorption–desorption isotherms. Their performance in assisting 385 nm UVA-LED CWPO treatment of acetaminophen (ACE), diclofenac (DCF), and metamizole (MTZ) was assessed under circumneutral pH conditions. The biochar-supported cerium-loaded catalyst prepared by oxygen-limited pyrolysis reported the highest activity, achieving 80% ACE and 70% DCF removals within 120 min of treatment, whereas MTZ was completely removed in less than 10 min, with only 16% of the removal attributable to adsorption. Superoxide radicals dominated the degradation mechanism, and photogenerated holes and hydroxyl radicals contributed moderately. Catalyst stability (minimal activity loss and negligible cerium leaching) was confirmed over five consecutive reuses. Degradation efficiency decreased ≈12–18% because of radical scavenging losses caused by the content of inorganic ions and organic matter in tap, river, and WWTP effluent waters. Treated effluents addressed lower toxicity than untreated solutions, reinforcing the environmental safety of this treatment strategy.
No takes yet. Share an insight, caveat, or question.
Muelas-Ramos et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: